Skip to main content
Vireo Growth Inc. logo

Vireo Growth Inc. — Investor Relations & Filings

Ticker · VREO ISIN · CA38238W1032 CSE Manufacturing
Filings indexed 543 across all filing types
Latest filing 2021-10-08 Regulatory Filings
Country CA Canada
Listing CSE VREO

About Vireo Growth Inc.

https://vireogrowth.com/

Vireo Growth Inc. is a science-focused cannabis company that cultivates, processes, and distributes medical and adult-use cannabis products. The company emphasizes environmentally friendly cultivation practices, often utilizing greenhouses, and manufactures pharmaceutical-grade cannabis extracts. Vireo Growth operates wholesale and retail business lines, selling its portfolio of branded products through company-owned dispensaries and distribution networks. The company's mission is to provide safe access, quality products, and value to its customers, coupled with a commitment to community support and restorative justice programs.

Recent filings

Filing Released Lang Actions
Material document(s).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Third Amendment to Lease Agreement' and contains detailed legal and financial terms related to a lease agreement between a landlord and tenant. It discusses amendments to lease terms, rent adjustments, tenant improvements, insurance requirements, and other contractual provisions. There is no indication that this is a financial report, regulatory filing, earnings release, or any other corporate filing type related to financial performance or governance. Instead, it is a legal contract amendment related to real estate leasing. Such documents do not fit into the predefined financial filing categories and are best classified under Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2021-10-08 English
Other.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving a purchase and sale agreement and a sale-leaseback transaction, as well as the creation of a direct financial obligation. There are no financial statements or detailed financial performance data included, only disclosures about transactions and agreements. This type of filing is typically categorized under Capital/Financing Update (CAP) because it relates to financing activities and changes in capital structure. The document is not an Annual Report, Earnings Release, or other detailed financial report, nor is it a simple announcement of a report publication. Therefore, the best classification is CAP with high confidence.
2021-09-30 English
News release - English.pdf
Regulatory Filings
2021-09-28 English
News release - English.pdf
Regulatory Filings
2021-09-14 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a community event hosted by Goodness Growth Holdings related to cannabis expungement clinics. It contains no financial data, no regulatory filing references, no financial results, no management or board changes, no voting results, no capital or financing updates, and no legal proceeding details. It is a general corporate announcement about a social initiative and community event. Therefore, it does not fit into any specific financial or regulatory filing category. The best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous corporate announcements that do not fit other categories.
2021-09-10 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Goodness Growth Holdings' subsidiary Resurgent Biosciences has received a patent for cannabis-based moist snuff products. It focuses on the patent issuance, the innovation, and the company's strategy and operations. There is no financial data, no regulatory filing references, no meeting materials, no voting results, no earnings or financial reports, and no mention of any report publication or certification. The content is primarily a corporate announcement about intellectual property and product innovation. This type of document fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit into more specific categories.
2021-09-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.